...
首页> 外文期刊>Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer >MET signalling pathway and its therapeutic implications in gastrointestinal cancers [La voie de signalisation MET et son implication thérapeutique dans les cancers digestifs]
【24h】

MET signalling pathway and its therapeutic implications in gastrointestinal cancers [La voie de signalisation MET et son implication thérapeutique dans les cancers digestifs]

机译:MET信号通路及其在消化道癌中的治疗意义[MET信号通路及其在消化道癌症中的治疗意义]

获取原文
获取原文并翻译 | 示例
           

摘要

The MET receptor tyrosine kinase and its ligand HGF regulates many signalling pathways involved in proliferation and cell motility, invasion and angiogenesis. Deregulation of HGFMET system by different biological mechanisms may contribute to the tumour development in many types of cancers. Some pharmacological approaches have been developed to inhibit the HGF-MET signalling pathway, using monoclonal antibodies against HGF or MET, or using tyrosine kinase inhibitors of MET receptor. In digestive cancers, several clinical studies have evaluated the safety and efficacy of these targeted therapies, with some promising results but requiring confirmation in phase III trials. Moreover, it appears that MET tumour expression could be a predictive marker of response to these targeted therapies for some gastrointestinal tumours. Thus, somatic alterations in HGF-MET system may represent interesting therapeutic targets and help to select patients who can favourably respond to such targeted treatment.
机译:MET受体酪氨酸激酶及其配体HGF调节涉及增殖和细胞运动,侵袭和血管生成的许多信号通路。通过不同的生物学机制使HGFMET系统失调可能有助于许多类型癌症的肿瘤发展。已经开发出一些药理学方法来抑制HGF-MET信号转导通路,方法是使用抗HGF或MET的单克隆抗体,或使用MET受体的酪氨酸激酶抑制剂。在消化道癌症中,一些临床研究已经评估了这些靶向疗法的安全性和有效性,并取得了一些有希望的结果,但需要在III期临床试验中加以证实。此外,似乎MET肿瘤表达可能是对某些胃肠道肿瘤针对这些靶向疗法的反应的预测性标志。因此,HGF-MET系统中的体细胞改变可能代表了有趣的治疗靶点,并有助于选择可以对这种靶向治疗产生良好反应的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号